News | March 02, 2009

Hansen Secures Exclusive Rights to Cardiac Ablation Technology

March 2, 2009 - Hansen Medical Inc. today announced an equity investment in Advanced Cardiac Therapeutics Inc. (ACT), and the procurement of certain exclusive rights to ACT’s patented microwave radiometry technology.

ACT is developing a novel technology that is designed to accurately measure the temperature in a lesion during cardiac ablation procedures.

Current manual technology used by physicians to control catheters in electrophysiology procedures can be limiting in several ways including, precise catheter control and stability, as well as the inability to accurately sense tissue temperature and its potential effect on lesion quality. The Sensei Robotic Catheter System from Hansen Medical can increase the control of electrophysiologic mapping catheters by using flexible medical robotics technology to provide stable and predictable control of catheter movement inside the heart.

ACT's patented Microwave Radiometry System has the potential to be incorporated into standard and irrigated cardiac catheters. A catheter with ACT's technology would have the potential to assist electrophysiologists by providing real-time feedback about effective energy delivery by the catheter.

ACT's technology has not been clinically tested and has not received regulatory approval.

"Accomplishing accurate and real-time temperature sensing has the potential to dramatically improve our ability to create safe, efficacious and persistent lesions," said Paul Wang, M.D., a leading electrophysiologist at Stanford University Medical Center.

For more information: www.hansenmedical.com

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems| December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems| January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems| November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init